Mepyramine
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a606008 |
ATC code | R06AC01 (WHO) D04AA02 (WHO) |
Identifiers | |
| |
Synonyms | N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyridin-2-amine |
CAS Number |
91-84-9 Y 59-33-6 (maleate) |
PubChem (CID) | 4992 |
IUPHAR/BPS | 1227 |
DrugBank | DB06691 N |
ChemSpider | 4818 Y |
UNII | HPE317O9TL Y |
KEGG | D08183 Y |
ChEBI | CHEBI:6762 N |
ChEMBL | CHEMBL511 Y |
ECHA InfoCard | 100.001.912 |
Chemical and physical data | |
Formula | C17H23N3O |
Molar mass | 285.38 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
NY (what is this?) (verify) |
Mepyramine, also known as pyrilamine, is a first generation antihistamine, targeting the H1 receptor.[1] However, it rapidly permeates the brain often causing drowsiness. It also has anticholinergic properties. It is used in over-the-counter combination products to treat the common cold and menstrual symptoms.[2] It is also the active ingredient of the topical antihistamine creams Anthisan and Neoantergan, sold for the treatment of insect bites, stings, and nettle rash.
Synthesis
See also
- Chloropyramine (chloro instead of methoxy)
References
- ↑ Parsons, Mike E.; Ganellin, C. Robin (January 2006). "Histamine and its receptors". British Journal of Pharmacology. 147 (S1): S127–S135. doi:10.1038/sj.bjp.0706440. PMC 1760721. PMID 16402096.
- ↑ Active Ingredients for Midol Complete
- ↑ R.J. Horclois, U.S. Patent 2,502,151 (1950).
- ↑ Huttrer, C. P.; Djerassi, C.; Beears, W. L.; Mayer, R. L.; Scholz, C. R. (1946). "Heterocyclic amines with antithistaminic activity". Journal of the American Chemical Society. 68 (10): 1999–2002. doi:10.1021/ja01214a037. PMID 21001124.
- ↑ D. Bovet, R. Horclois, F. Walthert, C.R. Soc. Biol., 138, 99 (1944).
Antihistamines for topical use | |
---|---|
Anesthetics for topical use | |
Others |
|
Aminoalkyl ethers |
|
---|---|
Substituted alkylamines | |
Substituted ethylenediamines |
|
Phenothiazine derivatives | |
Piperazine derivatives | |
Others for systemic use |
|
For topical use |
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Receptor (ligands) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (inhibitors) |
| ||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||
Others |
|
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.